Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer

2003 ◽  
Author(s):  
C. Robles ◽  
A. Furst ◽  
P. Sriratana ◽  
S. Lai ◽  
L. Chua ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Metastatic Prostate Cancer ◽  
Low Dose ◽  
Phase Ii Study ◽  
Hormone Refractory ◽  
Dose Prednisone

A PHASE II STUDY OF DOCETAXEL, ESTRAMUSTINE, AND LOW DOSE HYDROCORTISONE IN HORMONE REFRACTORY PROSTATE CANCER

1999 ◽  
pp. 296 ◽  
Author(s):  
Diane Savarese ◽  
Mary-Ellen Taplin ◽  
Bonnie Marchesani ◽  
Willi Kreis ◽  
Wallace Akerley ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting

2010 ◽  
Vol 40 (3) ◽  
pp. 201-208 ◽  
Author(s):  
S. Sewak ◽  
S. Kosmider ◽  
V. Ganju ◽  
A. Woollett ◽  
E. G. Yeow ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Metastatic Prostate Cancer ◽  
Phase Ii Study ◽  
Hormone Refractory

Phase II study combining gefitinib with etoposide in patients with hormone-refractory metastatic prostate cancer (mHRPC) after docetaxel-based therapy.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e15071-e15071
Author(s):  
R. J. Hauke ◽  
F. R. Loberiza ◽  
J. E. Elkahwaji ◽  
P. M. Townley ◽  
G. K. Bascom ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Metastatic Prostate Cancer ◽  
Phase Ii Study ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document